University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Institut Universitaire du Cancer de Toulouse, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Université Côte d’Azur - CNRS, Inserm, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toulouse 3, Paul Sabatier University - Physiopathology Center of Toulouse Purpan, University of Toulouse 3, Paul Sabatier University - Physiopathology Center of Toulouse Purpan, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Physiopathology Center of Toulouse Purpan, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory and University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT)

QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute - Gordon and Jessie Gilmour Leukemia Laboratory, University of Bonn - Institute of Experimental Oncology, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, Bristol Myers Squibb - Immuno-Oncology Discovery, Institut de recherches cliniques de Montréal (IRCM) - Laboratory of Molecular Oncology, University of Bonn - Institute of Experimental Oncology, University of Queensland - Pathology Queensland, The University of Sydney - Melanoma Institute Australia, The University of Sydney - Melanoma Institute Australia, The University of Sydney - Melanoma Institute Australia, University of Queensland - Royal Brisbane and Women’s Hospital, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, Bristol Myers Squibb - Immuno-Oncology Discovery, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory and QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory